Cover Image

Prognostic and Clinicopathological Significance of PD-L1 in Patients With Bladder Cancer: A Meta-Analysis

Background: The prognostic role of programmed cell death-ligand 1 (PD-L1) in bladder cancer has been investigated in previous studies, but the results remain inconclusive. Therefore, we carried out a meta-analysis to evaluate the prognostic significance of PD-L1 in patients with bladder cancer.Metho...

Full description

Saved in:

Bibliographic Details
Main Authors:	Lei Zhu (Author), Jin Sun (Author), Ling Wang (Author), Zhigang Li (Author), Lei Wang (Author), Zhibin Li (Author)
Format:	Book
Published:	Frontiers Media S.A., 2019-08-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The Clinicopathologic and Prognostic Significance of Programmed Cell Death Ligand 1 (PD-L1) Expression in Patients With Prostate Cancer: A Systematic Review and Meta-Analysis
by: Yan Li, et al.
Published: (2019)

The Prognostic and Clinicopathological Roles of PD-L1 Expression in Colorectal Cancer: A Systematic Review and Meta-Analysis
by: Yan Li, et al.
Published: (2019)

Prognostic and clinicopathological significance of survivin in gynecological cancer
by: Agapiti H. Chuwa, et al.
Published: (2024)

Prognostic significance of PD-L1 expression and CD8+ T cell infiltration in pulmonary neuroendocrine tumors
by: Haiyue Wang, et al.
Published: (2018)

Prognostic and Clinicopathological Significance of C-Reactive Protein to Albumin Ratio in Patients With Pancreatic Cancer: A Meta-Analysis
by: Qinfen Xie, et al.
Published: (2020)

Bioinformatics analysis of the clinicopathological and prognostic significance of BAG3 mRNA in gynecological cancers
by: Zi-mo Wang, et al.
Published: (2023)

The bioinformatics analysis of the clinicopathological and prognostic significances of REG4 mRNA in gynecological cancers
by: Cong-yu Zhang, et al.
Published: (2023)

Prognostic and clinicopathological significance of Fusobacterium nucleatum in colorectal cancer: a systemic review and meta-analysis
by: Younghoon Kim, et al.
Published: (2022)

The Clinicopathological and Prognostic Significance of the Gross Classification of Hepatocellular Carcinoma
by: Yangkyu Lee, et al.
Published: (2018)

The Prognostic Value of Gastric Immune Prognostic Index in Gastric Cancer Patients Treated With PD-1/PD-L1 Inhibitors
by: Li Chen, et al.
Published: (2022)

PD-L1 expression and the prognostic significance in gastric cancer: a retrospective comparison of three PD-L1 antibody clones (SP142, 28-8 and E1L3N)
by: Jing Ma, et al.
Published: (2018)

The clinicopathological significance of CDH1 in gastric cancer: a meta-analysis and systematic review
by: Zeng W, et al.
Published: (2015)

PD-L1 and PD-1 expression are correlated with distinctive clinicopathological features in papillary thyroid carcinoma
by: Yanhua Bai, et al.
Published: (2017)

Efficacy of PD-1/PD-L1 inhibitors in ovarian cancer: a single-arm meta-analysis
by: Jue Zhu, et al.
Published: (2021)

The clinicopathological significance and drug target potential of FHIT in breast cancer, a meta-analysis and literature review
by: Su Y, et al.
Published: (2015)

Prognostic Significance of the Modified Glasgow Prognostic Score in Patients With Pancreatic Cancer: A Meta-Analysis
by: Wen Fu, et al.
Published: (2020)

A bioinformatics analysis of the clinicopathological and prognostic significance of FAM64A mRNA expression in gynecological cancers
by: Hua-Chuan Zheng, et al.
Published: (2023)

Construction of an lncRNA model for prognostic prediction of bladder cancer
by: Changlong Shi, et al.
Published: (2022)

PD-L1 expression and its clinicopathological correlation in advanced esophageal squamous cell carcinoma in a Chinese population
by: Lulu Rong, et al.
Published: (2019)

β-Glucan Combined With PD-1/PD-L1 Checkpoint Blockade for Immunotherapy in Patients With Advanced Cancer
by: Mengjie Wang, et al.
Published: (2022)

Prognostic effect of programmed death-ligand 1 (PD-L1) in ovarian cancer: a systematic review, meta-analysis and bioinformatics study
by: Lin Wang
Published: (2019)

A Comprehensive Study on the Prognostic Value and Clinicopathological Significance of Different Immune Checkpoints in Patients With Colorectal Cancer: A Systematic Review and Meta-Analysis
by: Mahdieh Azizi, PhD, et al.
Published: (2024)

Clinicopathological features of tumor mutation burden, Epstein-Barr virus infection, microsatellite instability and PD-L1 status in Chinese patients with gastric cancer
by: Li Zhang, et al.
Published: (2021)

Prognostic and Predictive Significance of PD-L1 Expression in Non-Small Cell Lung Cancer Patients: A Single-Center Experience
by: Hacı ARAK, et al.
Published: (2021)

Relationship Between PD-L1, PD-1, CD8 and Clinicopathological Factors in Primary SCCs
by: Preslav Vasilev, et al.
Published: (2024)

Preoperative Systemic Inflammatory Markers as a Significant Prognostic Factor After TURBT in Patients with Non-Muscle-Invasive Bladder Cancer
by: Ding L, et al.
Published: (2023)

Effectiveness and safety of PD-1/PD-L1 inhibitors in advanced or recurrent endometrial cancer: a systematic review and meta-analysis
by: Songfei Han, et al.
Published: (2023)

Anterior Gradient 2 is a Significant Prognostic Biomarker in Bone Metastasis of Breast Cancer
by: Jin-Jin Li, et al.
Published: (2022)

Efficacy and safety of PD-1/PD-L1 inhibitors in the treatment of recurrent and refractory ovarian cancer: A systematic review and a meta-analysis
by: Siyuan Zeng, et al.
Published: (2023)

Prognostic Significance of VEGF-C Expression in Patients with Breast Cancer: A Meta-Analysis.
by: Bin Liang, et al.
Published: (2014)

Bioinformatic analysis of the clinicopathological and prognostic significance of oocyte-arresting BTG4 mRNA expression in gynecological cancers
by: Hua-chuan Zheng, et al.
Published: (2023)

Clinicopathological significance of matrix metalloproteinase-7 protein expression in esophageal cancer: a meta-analysis
by: Miao S, et al.
Published: (2015)

Prognostic significance of Cyclooxygenase-2 expression in colorectal adenoma and Adenocarcinoma: A clinicopathologic study
by: Noor I. Ibrahim, et al.
Published: (2023)

Biomarkers and prognostic factors of PD-1/PD-L1 inhibitor-based therapy in patients with advanced hepatocellular carcinoma
by: Nan Zhang, et al.
Published: (2024)

Integrative multi-omics analysis depicts the methylome and hydroxymethylome in recurrent bladder cancers and identifies biomarkers for predicting PD-L1 expression
by: Zhen-Duo Shi, et al.
Published: (2023)

BCG downregulates PD1 and PD-L1 expression in bladder cancer cells co-cultivated with peripheral blood mononuclear cells
by: Katia R. M. Leite, et al.
Published: (2022)

The Prognostic and Therapeutic Value of PD-L1 in Glioma
by: Ruo Qiao Chen, et al.
Published: (2019)

Prognostic value of lung immune prognostic index in non-small cell lung cancer patients receiving immune checkpoint inhibitors: a meta-analysis
by: Yi Wang, et al.
Published: (2024)

PD-1/PD-L1 Inhibitors in Cervical Cancer
by: Yuncong Liu, et al.
Published: (2019)

Identification of novel lactate metabolism-related lncRNAs with prognostic value for bladder cancer
by: Xiushen Wang, et al.
Published: (2023)